Clinical Trial: ALLIANCE A081801

ALLIANCE A081801

Status: Open

Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)

(See required screening study ALLIANCE A151216)